We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Abbott has received the US Food and Drug Administration (FDA) approval for its latest optical coherence tomography (OCT) imaging platform powered by its new Ultreon Software. The new
AstraZeneca has received the US Food and Drug Administration (FDA) approval for Saphnelo (anifrolumab-fnia) to treat moderate to severe systemic lupus erythematosus (SLE) in adults, who are receiving
Autolus Therapeutics has reached a licence agreement with Moderna for the development and marketing of mRNA therapeutics for up to four immuno-oncology targets. Moderna is a biotechnology company
Japanese pharmaceutical firm Takeda has teamed up with US-based venture capital firm Frazier Healthcare Partners to create a new biopharmaceutical company HilleVax. HilleVax is designed to develop and
Janssen, the pharmaceutical company of Johnson & Johnson (J&J), has received the US Food and Drug Administration (FDA) approval for Uptravi (selexipag) to treat a type of pulmonary
Loxo Oncology at Lilly, a company of Eli Lilly (Lilly), has entered into an exclusive collaboration with Kumquat Biosciences to focus on novel small molecule therapies. The collaboration
GSK has received the US Food and Drug Administration (FDA) approval for Nucala (mepolizumab) to treat adults with chronic rhinosinusitis with nasal polyps (CRSwNP). Nucala is a monoclonal
Sanofi India, previously known as Aventis Pharma, has announced that its board of directors approved the sale of its nutraceuticals business to Universal Nutrisciences for a total of
GSK and Vir Biotechnology have signed a joint procurement agreement with the European Commission (EC) for up to 220,000 doses of sotrovimab, an investigational Covid-19 drug. Sotrovimab is
Amgen has agreed to acquire Teneobio, a clinical-stage biotechnology company focused on a new class of biologics, dubbed Human Heavy-Chain Antibodies. Under the terms of the agreement, Amgen